Register Now

The global pharma industry is going through a reset. Healthcare priorities are shifting, supply chains are being reconsidered, and expectations around quality, reliability and innovation are higher than ever before. Around the world, countries are looking for partners they can trust. Not just during crises, but for the long term.

India Pharma has earned that trust over decades. But today, the industry stands at a new crossroads.

The next phase is not only about supplying medicines at scale. It is about competing through innovation, strengthening global credibility, and building resilient systems that can support future healthcare needs.

Key Topics:
♦ The new innovation economy: Building the ecosystem behind the molecule
• Why ecosystems outperform individual companies
• Strengthening industry–academia collaboration
• The role of venture capital and public funding
• Creating a faster path from lab to market

♦ The biopharma pivot: Can India move from manufacturing medicines
to inventing them?
• Transitioning from biosimilars to novel biologics
• Funding and commercialising innovation
• Building translational research ecosystems
• The role of Bengaluru in driving discovery

♦ The Bengaluru Bet: How GCCs are redening India Pharma Inc
• Are GCCs becoming innovation hubs?
• How are they changing talent and leadership?
• Collaboration between GCCs, startups and academia
• What this means for India’s global pharma positioning

For more information: https://bengalurusummit.expresspharma.in/